These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2544821)

  • 41. Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor.
    Wong KR; Xie MH; Shi LB; Liu FY; Huang CL; Gardner DG; Cogan MG
    Am J Physiol; 1988 Dec; 255(6 Pt 2):F1220-4. PubMed ID: 2849318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
    Carstens J; Pedersen EB
    Scand J Clin Lab Invest; 2008; 68(1):2-10. PubMed ID: 17852806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of angiotensin converting enzyme inhibition on renal response to atrial natriuretic factor in rats.
    Wu JN; Huang WC
    Proc Natl Sci Counc Repub China B; 1988 Jul; 12(3):186-93. PubMed ID: 2977443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attenuation of renal effects of atrial natriuretic factor during rat pregnancy.
    Omer S; Mulay S; Cernacek P; Varma DR
    Am J Physiol; 1995 Mar; 268(3 Pt 2):F416-22. PubMed ID: 7900841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure.
    Abassi Z; Burnett JC; Grushka E; Hoffman A; Haramati A; Winaver J
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R858-64. PubMed ID: 1656791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
    Minutolo R; Andreucci M; Balletta MM; Russo D
    Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atrial natriuretic factor counteracts sodium-retaining actions of insulin in normal men.
    Miller JA; Abouchacra S; Zinman B; Skorecki KL; Logan AG
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R584-90. PubMed ID: 8214150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
    Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of clonidine and dihydralazine on plasma ANF and cyclic GMP levels in humans during volume loading.
    Müller T; Heim JM; Weil J; Wehling M; Witzgall H; Gerzer R
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S163-6. PubMed ID: 2455172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influence of plasma alpha-human atrial natriuretic polypeptide on natriuretic and diuretic effects in patients with nephrotic syndrome].
    Wang YX; Lin SY; Qiu CL
    Zhonghua Nei Ke Za Zhi; 1990 Oct; 29(10):589-92, 636. PubMed ID: 1964888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
    Burnier M; Mooser V; Wauters JP; Marder HK; De Vane P; Nussberger J; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iso-oncotic volume expansion in the nephrotic syndrome.
    Rabelink TJ; Bijlsma JA; Koomans HA
    Clin Sci (Lond); 1993 Jun; 84(6):627-32. PubMed ID: 8334809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of atrial natriuretic factor on renal cGMP production in rats with adriamycin-induced nephrotic syndrome.
    Abassi Z; Shuranyi E; Better OS; Winaver J
    J Am Soc Nephrol; 1992 Apr; 2(10):1538-44. PubMed ID: 1318109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-human atrial natriuretic polypeptide-induced rise of plasma and urinary cyclic 3'5'-guanosine monophosphate concentration in human subjects.
    Ohashi M; Fujio N; Nawata H; Kato K; Ibayashi H
    Clin Exp Hypertens A; 1986; 8(1):67-73. PubMed ID: 3011321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary excretion of guanosine 3':5'-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment.
    Krieger J; Schmidt M; Sforza E; Lehr L; Imbs JL; Coumaros G; Kurtz D
    Clin Sci (Lond); 1989 Jan; 76(1):31-7. PubMed ID: 2537703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome.
    Zietse R; Schalekamp MA
    Kidney Int; 1988 Nov; 34(5):717-24. PubMed ID: 2974095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal handling of sodium in the nephrotic syndrome.
    Perico N; Remuzzi G
    Am J Nephrol; 1993; 13(5):413-21. PubMed ID: 8116693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.
    Brown EA; Markandu N; Sagnella GA; Jones BE; MacGregor GA
    Nephron; 1985; 39(4):290-5. PubMed ID: 3982574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.